Antiretroviral therapy for adults infected with HIV: Guidelines for health care professionals from the Quebec HIV care committee

Author:

Rouleau Danielle1,Fortin Claude1,Trottier Benoît12,Lalonde Richard3,Lapointe Normand4,Côté Pierre156,Routy Jean-Pierre3,Matte Marie-France7,Tsarevsky Irina7,Baril Jean-Guy157,

Affiliation:

1. Unité hospitalière de recherche, d’enseignement et de soins sur le sida (UHRESS), Centre hospitalier de l’Université de Montréal, Canada

2. Clinique médicale l’Actuel, Canada

3. UHRESS, McGill University Health Centre, Canada

4. UHRESS, Centre hospitalier universitaire Sainte-Justine, Université de Montréal, Canada

5. Clinique médicale du Quartier Latin, Canada

6. Programme national de mentorat sur le VIH-sida, Canada

7. Service de lutte contre les infections transmissibles sexuellement par le sang, Ministère de la Santé et des Services sociaux, Montréal, Québec, Canada

Abstract

The appropriate use of antiretrovirals reduces morbidity and mortality caused by HIV infection. The present article provides health care professionals with a practical guide for the use of antiretrovirals. Therapy should be initiated based predominantly on clinical presentation and CD4 count, and should consist of three active drugs or at least two active drugs when this is not possible, as in cases of some treatment-experienced patients. This is the most effective way to achieve long-term suppression of viral replication. Selection of individual drugs in the regimen should consider the weight of the evidence supporting these choices, as well as their tolerability profiles and ease of use, the patients’ comorbidities and treatment history. Treatment interruption is not recommended, either in aviremic patients or in those who have experienced virological failure. Instead, the therapeutic regimen should be adjusted to minimize side effects, promote adherence and suppress viral replication.

Publisher

Hindawi Limited

Subject

Infectious Diseases,Microbiology (medical)

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3